Pyridine

Pyridine

SCHEMBL2190976

C#CC1c2c([nH]c3ccc(C)cc23)CCN1C.c1ccncc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
ACHE P22303 5/20 0.40
GRIN1 Q05586 3/20 0.39
GRIN2A Q12879 3/20 0.39
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39
GRIN2B Q13224 2/20 0.39
GRIN2C Q14957 2/20 0.39
GRIN3A Q8TCU5 2/20 0.39
MCHR1 Q99705 1/20 0.39
KIF11 P52732 1/20 0.37
BAZ2B Q9UIF8 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
HTR6 P50406 2/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
GLA P06280 1/20 0.35
LMNA P02545 1/20 0.35
PABPC1 P11940 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2188382 0.87 SIRT2 (0.47) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
Isoquinoline SCHEMBL12480425 0.86 L3MBTL1 (0.38) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
Hydrochlorthiazide SCHEMBL2186510 0.86 L3MBTL1 (0.39) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL2188024 0.82 L3MBTL1 (0.41) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL2187782 0.82 L3MBTL1 (0.41) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL12480560 0.81 L3MBTL1 (0.37) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL12481058 0.78 L3MBTL1 (0.36) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL12480504 0.74 L3MBTL1 (0.53) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL12479636 0.70 MAP2K4 (0.42) L3MBTL1ACHEGRIN1GRIN2AGRIN2D
SCHEMBL15570026 0.70 L3MBTL1 (0.49) L3MBTL1ACHEGRIN1GRIN2AGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2015-02-19 US disclosed
US-8907097-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-8906925-B2 Pyrido[4,3-B]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2013-07-25 US disclosed
EP-2346332-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES Medivation Technologies, Inc. (US) 2011-07-27 EP disclosed
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2010-08-26 US disclosed
WO-2010051501-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A L3MBTL1 2178/4885ACHE 118/4885GRIN1 95/4885
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A L3MBTL1 2178/4885ACHE 118/4885GRIN1 95/4885
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A L3MBTL1 2178/4885ACHE 118/4885GRIN1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.